GSK(GSK plc) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $33.95B | $36.15B | $37.85B | $40.17B | $43.12B |
| 毛利润 | $22.73B | $24.37B | $27.16B | $28.58B | $31.22B |
| 营业利润 | $5.99B | $7.93B | $8.42B | $5.15B | $10.47B |
| 净利润 | $6.03B | $18.44B | $6.15B | $3.30B | $7.55B |
| 经营现金流 | $10.93B | $9.13B | $8.45B | $8.39B | $10.22B |
| 自由现金流 | $9.63B | $7.72B | $6.81B | $6.60B | $8.44B |
| 摊薄每股收益 | $1.49 | $4.51 | $1.50 | $0.80 | $1.83 |